Related Experiment Video
Updated: Jan 23, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Chronotropic incompetence as a risk predictor in children and young adults with catecholaminergic polymorphic
Sonia Franciosi1, Thomas M Roston1,2,3, Frances K G Perry1
1Division of Cardiology, Department of Pediatrics, Children's Heart Centre, BC Children's Hospital, University of British Columbia, Vancouver, Canada.
Insights
Chronotropic incompetence (CI) during exercise stress tests is linked to worse outcomes in catecholaminergic polymorphic ventricular tachycardia (CPVT) patients. However, antiarrhythmic therapy may mitigate this risk, suggesting CI
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) poses a significant risk of life-threatening arrhythmias.
- Current risk stratification tools for CPVT are limited, highlighting the need for improved prognostic markers.
- The exercise stress test (EST) is crucial for diagnosing and assessing the prognosis of CPVT.
Purpose of the Study:
- To investigate the association between heart rate (HR) and blood pressure (BP) response during EST and the risk of arrhythmias in CPVT patients.
- To determine if chronotropic incompetence (CI) during EST is a predictor of ventricular arrhythmia burden.
- To assess the impact of antiarrhythmic therapy on the prognostic value of CI and BP response in CPVT.
Main Methods:
- A cohort of 20 CPVT patients underwent EST.
- Chronotropic incompetence (CI) was defined by HR reserve values <80% (off therapy) and ≤62% (on therapy).
- Ventricular arrhythmia score (VAS), syncope, cardiac arrest, and BP response during EST were analyzed in relation to CI, both off and on maximal antiarrhythmic therapy.
Main Results:
- CI in untreated CPVT patients was associated with a higher VAS during EST (P=.046) and a greater frequency of syncope/cardiac arrest (P=.008).
- Patients with CI exhibited lower peak systolic BP during EST (P=.041), a finding that persisted on maximal therapy (P=.033).
- Antiarrhythmic therapy appeared to attenuate the increased arrhythmia risk associated with CI, as VAS was similar between CI and non-CI groups on therapy (P=.50).
Conclusions:
- Chronotropic incompetence during EST is a significant prognostic indicator for ventricular arrhythmias and adverse events in untreated CPVT patients.
- Antiarrhythmic therapy may modify the risk associated with CI, suggesting its potential as a therapeutic target.
- Further research is warranted to confirm these findings in larger cohorts and elucidate the underlying mechanisms linking CI to arrhythmia susceptibility in CPVT.
Introduction:
Risk stratification tools for catecholaminergic polymorphic ventricular tachycardia (CPVT) are limited. The exercise stress test (EST) is the most important diagnostic and prognostic test. We aimed to determine whether heart rate (HR) and blood pressure (BP) response during EST were associated with the risk of arrhythmias.
Materials And Methods:
We studied the association between HR and BP response and ventricular arrhythmia burden on EST in 20 CPVT patients. HR reserve values <80% and ≤62% were used to define chronotropic incompetence (CI) off and on therapy, respectively. Symptoms and ventricular arrhythmia score (VAS) in all patients with respect to CI and BP during index EST off therapy and on maximal therapy were compared.
Results:
CI in CPVT patients off therapy was associated with a worse VAS during EST (P = .046). Patients with CI also more frequently presented with syncope and/or cardiac arrest compared to patients with a normal chronotropic response (P = .008). Once on therapy, patients with CI had similar VAS compared to patients without CI (P = .50), suggesting that treatment attenuates risk related to CI. Patients with CI also had a lower peak systolic BP (P = .041) which persisted on maximal therapy (P = .033).
Conclusion:
Untreated CPVT patients with CI have more ventricular arrhythmias than those without CI. This may serve as a simple disease prognosticator that can be modified by antiarrhythmic therapy. A mechanistic link between CI and arrhythmia susceptibility remains unknown. Larger studies are needed to confirm and establish the mechanism of these findings.
More Related Videos
Related Concept Videos
Relative Risk
Single Nucleotide Polymorphisms-SNPs
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Drug Dosing: Infants and Children
Adult Stem Cells

